Dr. Pirie currently serves as co-founder CEO of Virvio, an early stage biopharmaceutical design company whose platform technology creates alternatives to antibody drugs. Prior to Virvio, he was co-founder and Director of Protein Engineering at Manus Bio, a synthetic biology company developing renewable biosynthetic processes for flavors, fragrances, and sweeteners. There he led a world-class team of researchers in creating cutting edge techniques for engineering enzymes. In addition to these entrepreneurial endeavors, he has specialized in business development of corporate research partnerships and prosecution of intellectual property.
Dr. Pirie earned his PhD and conducted post-doctoral research at the Koch Institute for Integrative Cancer Research at MIT. Also while at MIT, he served two years as representative to the Institute Committee on Intellectual Property and was a founding writer and editor in biotechnology for the MIT Entrepreneurship Review. He is a graduate of the global Startup Leadership Program and enjoys engaging young entrepreneurs while discovering new strategies for academic technology commercialization. He received his bachelors of science degree in Bioengineering from the University of Washington and is an avid soccer player.